We are a one-stop-shop for rich data and rolling legal and business insights across East Africa on matters of public policy and regulatory affairs. We serve as policy analysts, regulatory experts and strategy advisers to a wide breadth of clientele with the aim of helping them manage change, mitigate risk and resolve disputes. The team is made up of lawyers, political and economic pundits with vast experiences drawn from corporate law, public affairs, academia, research, social development with each practice demonstrating expertise, in depth knowledge and a proven track record of making an impact.
Former Prime Minister and Azimio presidential candidate Raila Odinga is at a crossroads in his political career. He has to choose between leading the Opposition from outside Parliament or walking away from politics and into some form of retirement. This week, he appeared to swing
Post- Election Snapshot On Monday 21st, The Employment Court extended orders issued last week stopping the PS nominees’ vetting. Justice Nduma Nderi extended the order to next Tuesday when he will deliver a ruling on the issue of jurisdiction that was raised by the National
Tuesday 22nd November; The Senate MOTION The County Governments Additional Allocations (No. 2) Bill (Senate bills No. 4 of 2022) (Resumption of debate interrupted on Thursday, November 17, 2022 – Afternoon Sitting) Integrating Climate Education into the National Education Curriculum.
Kenya Court stops law allowing workers to withdraw pension for home purchase A High Court has stopped the implementation of the Retirement Benefits (Mortgage Loans) (Amendment) Regulations, 2020 which allows workers to withdraw part of their pension to buy a home. Justice Anthony Ndung’u said
KENYA MPs back push for private land holding caps Parliament has approved a fresh attempt to have the government cap the size of land an individual can hold. MPs have backed a proposal that seeks to compel the Ministry of Lands to make rules and
WHO is launching a global scientific process to update the list of priority pathogens—agents that can cause outbreaks or pandemics—to guide global investment, research and development (R&D), especially in vaccines, tests and treatments. Starting with a meeting held last Friday, 18 November, WHO is convening